Showing results (1841-1850 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|September 10, 2016
Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting AutophagyYang Sun, Long Jin, Jia-Hua Liu, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2017
In Vitro Evaluation of 188Re-HEDP: A Mechanistic View of Bone Pain PalliationsRohit Sharma, Chandan Kumar, Madhava B Mallia, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2017
Development of 68Ga-SCN-DOTA-Capsaicin as an Imaging Agent Targeting Apoptosis and Cell Cycle Arrest in Breast CancerJun Young Lee, Sang-Yeun Lee, Gun Gyun Kim, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor modelHaladhar D Sarma, Tapas Das, Sharmila Banerjee, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagyJing-Hua Ren, Wen-Shan He, Li Nong, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivoSyed Ali Raza Naqvi, Torkjel Matzow, Ciara Finucane, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoterLadan Teimoori-Toolabi, Kayhan Azadmanesh, Sirous Zeinali
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOCMaribel L Sierra, Alberto Agazzi, Lisa Bodei, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Signaling defects and functional impairment in T-cells from cervical cancer patientsVino T Cheriyan, Smriti M Krishna, Aswin Kumar, et al.
Pageof 224